MTHFR rs1801131: Understanding the A1298C Genetic Variant
The MTHFR rs1801131 variant is a common genetic change in the MTHFR gene that results in a minor reduction of enzyme activity. While often discussed in wellness circles, major clinical guidelines indicate that this variant does not independently cause significant health conditions.
What each genotype means
Typical MTHFR enzyme activity
You carry two copies of the standard A allele, which is associated with baseline MTHFR enzyme activity and typical folate metabolism. Current clinical guidelines and large population studies indicate this genotype is not linked to altered homocysteine levels or independent thrombophilia risks. Standard nutritional guidelines for dietary folate intake remain sufficient for individuals with this profile.
Carried by approximately 40% to 50% of individuals of European ancestry and over 60% of individuals of African or East Asian ancestry.
Slightly reduced enzyme activity
You have one copy of the c.1298A>C missense variant, which is associated with a minor decrease in MTHFR enzyme activity in laboratory assays. However, clinical consensus guidelines and large-scale genetic studies show that being heterozygous does not independently cause elevated homocysteine or adverse cardiovascular and clotting outcomes in isolation. Any potential metabolic effect is generally considered negligible unless accompanied by severe folate deficiency or co-inherited risk variants.
Carried by roughly 40% to 45% of individuals in European populations, and between 25% and 35% of individuals of African and East Asian descent.
Modestly reduced enzyme activity
You carry two copies of the c.1298A>C variant, which results in a modest reduction in MTHFR catalytic efficiency. Despite earlier historical hypotheses, major clinical guidelines and ClinVar classifications view this genotype as benign on its own, with no proven independent link to elevated homocysteine or vascular disease. For individuals taking medications that interact with the folate pathway, such as methotrexate or fluorouracil, dosing choices should always be evaluated with a clinician or pharmacist.
Present in about 9% to 12% of individuals of European descent, roughly 2% to 4% in East Asian populations, and up to 19% in certain South Asian groups.
What is rs1801131?
The rs1801131 variant, often referred to as A1298C or p.Glu429Ala, is a single nucleotide polymorphism (SNP) located within the MTHFR gene. This gene provides instructions for making the methylenetetrahydrofolate reductase enzyme. In this specific variant, the DNA base adenine (A) is replaced by cytosine (C) at position 1298. This change leads to a substitution of the amino acid glutamic acid with alanine in the resulting protein structure. Because this variant is located in the regulatory domain of the enzyme, it has been studied extensively for its potential to alter how the body processes folate. While it is a common genetic variation found in many healthy individuals, researchers have spent decades investigating whether this specific change influences susceptibility to various health conditions, ranging from cardiovascular issues to certain types of cancer.
The Role of the MTHFR Gene
The MTHFR gene is essential for the body's folate cycle, a complex series of chemical reactions that allow the body to process vitamins and amino acids. Specifically, the MTHFR enzyme converts 5,10-methylenetetrahydrofolate into 5-methyltetrahydrofolate. This product is a critical component in the conversion of the amino acid homocysteine into methionine, which the body needs for protein synthesis and DNA methylation. When MTHFR enzyme activity is significantly impaired, it can theoretically lead to elevated levels of homocysteine in the blood, a condition known as hyperhomocysteinemia. However, the rs1801131 variant is generally considered to have a much milder impact on enzyme function compared to other variants like rs1801133 (C677T). Most individuals with the rs1801131 variant maintain sufficient enzyme activity to support normal metabolic processes, especially when dietary folate intake is adequate.
Clinical Significance and Research
The clinical significance of rs1801131 is a subject of ongoing research, but current medical consensus suggests it has little to no independent impact on health. While some early or smaller studies suggested links between this variant and conditions like cardiovascular disease, pregnancy complications, or certain cancers, these findings have often been inconsistent or failed to be replicated in larger, more rigorous studies. Major health organizations and clinical guidelines generally do not recommend testing for this variant because it does not change standard medical management. It is important to note that while some studies suggest that having both the rs1801131 and rs1801133 variants (compound heterozygosity) might influence homocysteine levels, even this effect is often manageable through a balanced diet. Always consult with a healthcare provider or a genetic counselor to interpret genetic results in the context of your overall health and family history.
Population Frequency
The rs1801131 variant is relatively common across global populations, though its frequency varies by ancestry. The minor allele (C) is found in approximately 30% to 35% of European populations, while it is less common in African and East Asian populations, typically appearing at frequencies between 15% and 20%. Because this variant is so prevalent, it is considered a normal part of human genetic diversity rather than a rare mutation. The high frequency of this variant across diverse groups underscores that carrying the C allele is not inherently associated with disease. Most people who carry one or two copies of the C allele live healthy lives without any clinical symptoms related to their MTHFR genotype. Understanding these population-level statistics helps put individual test results into a broader, more accurate perspective.
What You Can Do With This Information
If you have received information about your MTHFR rs1801131 status, it is helpful to remember that genetic variants are only one piece of the health puzzle. Because this variant is not considered a primary cause of disease, most medical professionals do not use this information to guide treatment or diagnostic decisions. The most effective way to support your health is to focus on established lifestyle factors, such as maintaining a balanced diet rich in folate-containing foods like leafy greens, legumes, and fortified grains. If you are concerned about your homocysteine levels or folate status, your doctor can order standard blood tests to measure these markers directly, which provides much more actionable information than a genetic test alone. Avoid making significant changes to your health regimen based solely on this SNP, and always discuss any concerns about supplements or medications with your clinician.
How common is this variant?
The minor allele (C) frequency is approximately 0.30–0.35 in European populations, 0.15–0.20 in African populations, and 0.15 in East Asian populations.
Frequently asked questions
Should I take special supplements for my MTHFR variant?
There is no clinical evidence that individuals with the rs1801131 variant require specific supplements beyond a standard, healthy diet. Always consult your doctor before starting any new supplement regimen.
Does this variant cause high homocysteine?
The rs1801131 variant alone is not typically associated with significantly elevated homocysteine levels. If you are concerned about your homocysteine, a blood test is the only way to know your current levels.
Is MTHFR testing recommended by doctors?
No, major medical organizations do not recommend routine testing for MTHFR variants like rs1801131. The results generally do not change how doctors manage your health.
Can I process folic acid if I have this variant?
Yes, individuals with this variant can process folic acid and other forms of folate normally. A balanced diet is sufficient for most people to meet their nutritional needs.
Sources & further reading
Educational information only, last refreshed 10/17/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1801131?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in MTHFR
Variant in the MTHFR locus frequently studied in association with folate metabolism and homocysteine levels.
MTHFR missense variant (c.1793G>A, p.Arg594Gln) commonly evaluated alongside canonical variants for folate metabolism and hyperhomocysteinemia predisposition.
Functional polymorphism influencing homocysteine dynamics and vascular endothelial recovery during high-intensity training.
Common variant (C677T) influencing folate metabolism and plasma homocysteine levels.
The C677T variant in the MTHFR gene is associated with reduced enzyme activity and mild hyperhomocysteinemia, particularly in individuals with low folate intake.
The MTHFR 677C>T (Ala222Val) variant encodes a thermolabile enzyme with reduced activity. While associated with elevated homocysteine levels in the presence of low folate, major professional guidelines (e.g., ACMG) advise against routine clinical testing for cardiovascular or thrombophilia risk due to lack of clinical utility.